1,588 reports of this reaction
1.3% of all ONABOTULINUMTOXINA reports
#17 most reported adverse reaction
WRONG TECHNIQUE IN DRUG USAGE PROCESS is the #17 most commonly reported adverse reaction for ONABOTULINUMTOXINA, manufactured by Allergan, Inc.. There are 1,588 FDA adverse event reports linking ONABOTULINUMTOXINA to WRONG TECHNIQUE IN DRUG USAGE PROCESS. This represents approximately 1.3% of all 126,795 adverse event reports for this drug.
ONABOTULINUMTOXINA has an overall safety score of 78 out of 100. Patients taking ONABOTULINUMTOXINA who experience wrong technique in drug usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WRONG TECHNIQUE IN DRUG USAGE PROCESS is a less commonly reported adverse event for ONABOTULINUMTOXINA, but still significant enough to appear in the safety profile.
In addition to wrong technique in drug usage process, the following adverse reactions have been reported for ONABOTULINUMTOXINA:
The following drugs have also been linked to wrong technique in drug usage process in FDA adverse event reports:
WRONG TECHNIQUE IN DRUG USAGE PROCESS has been reported as an adverse event in 1,588 FDA reports for ONABOTULINUMTOXINA. This does not prove causation, but indicates an association observed in post-market surveillance data.
WRONG TECHNIQUE IN DRUG USAGE PROCESS accounts for approximately 1.3% of all adverse event reports for ONABOTULINUMTOXINA, making it a notable side effect.
If you experience wrong technique in drug usage process while taking ONABOTULINUMTOXINA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.